SIRT7 and coronary artery disorder: Notably, after adjustment for WBC, CK-MB levels, and antiplatelet therapy use, each unit increase in SIRT7 was associated with a 97% elevated risk of CAD (adjusted OR: 1.97; 95% CI 1.48–2.63; P < 0.001).